76 related articles for article (PubMed ID: 17624914)
21. Fluoxetine versus placebo in advanced cancer outpatients.
Alliot C
J Clin Oncol; 2004 Jan; 22(1):204-5; author reply 206-8. PubMed ID: 14701790
[No Abstract] [Full Text] [Related]
22. Newer antidepressants for hot flashes--should their efficacy still be up for debate?
Loprinzi CL; Barton DL; Sloan JA; Novotny PJ; Wolf S
Menopause; 2009; 16(1):184-7. PubMed ID: 18725865
[TBL] [Abstract][Full Text] [Related]
23. Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study.
Kowatch RA; Carmody TJ; Emslie GJ; Rintelmann JW; Hughes CW; Rush AJ
J Affect Disord; 1999 Aug; 54(3):269-76. PubMed ID: 10467970
[TBL] [Abstract][Full Text] [Related]
24. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
Pedrelli P; Feldman GC; Vorono S; Fava M; Petersen T
Psychiatry Res; 2008 Dec; 161(3):302-8. PubMed ID: 18976817
[TBL] [Abstract][Full Text] [Related]
25. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
26. "Wish bias" in antidepressant drug trials?
Barbui C; Cipriani A; Brambilla P; Hotopf M
J Clin Psychopharmacol; 2004 Apr; 24(2):126-30. PubMed ID: 15206658
[TBL] [Abstract][Full Text] [Related]
27. Treatment of habit-tic deformity with fluoxetine.
Vittorio CC; Phillips KA
Arch Dermatol; 1997 Oct; 133(10):1203-4. PubMed ID: 9382557
[No Abstract] [Full Text] [Related]
28. Going beyond Prozac.
Miller MC
Newsweek; 2003 Dec; 142(23):69-70. PubMed ID: 14712565
[No Abstract] [Full Text] [Related]
29. The valorization of sadness. Alienation and the melancholic temperament.
Kramer PD
Hastings Cent Rep; 2000; 30(2):13-8. PubMed ID: 10763466
[No Abstract] [Full Text] [Related]
30. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
31. European agency approves use of fluoxetine for children and teens.
Eaton L
BMJ; 2006 Jun; 332(7555):1407. PubMed ID: 16777864
[No Abstract] [Full Text] [Related]
32. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
33. Placebos and relapse in depression.
Harv Ment Health Lett; 1999 Feb; 15(8):7. PubMed ID: 9990251
[No Abstract] [Full Text] [Related]
34. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial.
Gariballa S; Forster S
Clin Nutr; 2007 Oct; 26(5):545-51. PubMed ID: 17662509
[TBL] [Abstract][Full Text] [Related]
35. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
36. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
38. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
39. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Wearden AJ; Morriss RK; Mullis R; Strickland PL; Pearson DJ; Appleby L; Campbell IT; Morris JA
Br J Psychiatry; 1998 Jun; 172():485-90. PubMed ID: 9828987
[TBL] [Abstract][Full Text] [Related]
40. Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Deale A; Chalder T; Wessely S
Br J Psychiatry; 1998 Jun; 172():491-2. PubMed ID: 9828988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
